![](/img/cover-not-exists.png)
Parallel in-vivo assessment of drug phenotypes at various time points during systemic BRAF inhibition reveals tumor adaptation and altered treatment vulnerabilities
Jonas, O., Oudin, M. J., Kosciuk, T., Whitman, M., Gertler, F. B., Cima, M. J., Flaherty, K. T., Langer, R.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-2722
Date:
April, 2016
File:
PDF, 1.36 MB
english, 2016